drugset / Trial / NCT05109377

Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

NCT05109377

RandomizedParallel-groupSingle-blindDiagnostic

Summary

The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.

Timeline

Start
2021-06-24
Primary completion
2021-11-15
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg
Subject Tadalafil Small molecule 20 mg

Indications